← Back to Search

High Intensity Walking for Frailty

Waitlist Available
Led By Margaret Danilovich, PhD
Research Sponsored by Northwestern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Able to ambulate at least 10 feet with moderate assistance (<50% physical assistance) or less. Participants will be able to use their assistive device (e.g. cane or walker) during sessions.
> 60 years of age with pre-frailty or frailty as determined on the SHARE-FI.
Screening 3 weeks
Treatment Varies
Follow Up baseline and four months
Awards & highlights

Study Summary

This trial tests how different levels of walking can affect frailty, mobility, physical function, balance, and overall activity in seniors.

Who is the study for?
This trial is for people over 60 who are somewhat to very frail, can walk at least 10 feet with little help or using a cane/walker, and live in one of the selected retirement communities. They must be able to give informed consent and pass a health check. People with recent severe heart issues, uncontrolled diabetes, or extremely high blood pressure cannot join.Check my eligibility
What is being tested?
The study is looking at how different walking speeds affect frailty levels and scores using the SHARE-FI tool. It also examines changes in mobility, physical function, balance, and overall physical activity due to these walking exercises.See study design
What are the potential side effects?
While not explicitly stated here, potential side effects from participating could include muscle soreness or strain from increased physical activity.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
I can walk at least 10 feet with little help or using a device like a cane.
I am over 60 and considered pre-frail or frail based on a health assessment.


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and four months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and four months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in frailty as measured by the Survey of Health, Ageing, and Retirement in Europe-Frailty Instrument (SHARE-FI)
Secondary outcome measures
Improved balance as measured by the Berg Balance Scale
Improved balance as measured by the Falls Efficacy
Improved mobility as measured by 6 Minute Walk Test
+4 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: High Intensity WalkingExperimental Treatment1 Intervention
HIW (70-80% HRmax)
Group II: Casual Speed WalkingExperimental Treatment1 Intervention
Self selected pace

Find a Location

Who is running the clinical trial?

Northwestern UniversityLead Sponsor
1,585 Previous Clinical Trials
917,075 Total Patients Enrolled
5 Trials studying Frailty
1,825 Patients Enrolled for Frailty
Margaret Danilovich, PhDPrincipal Investigator - Northwestern University
Northwestern University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the total recruitment of participants for this research?

"Affirmative. On the clinicaltrials.gov website, it is apparent that this medical experiment commenced on November 26th 2018 and has been recently updated on April 7th 2022. 200 participants are currently required from 1 site of recruitment."

Answered by AI

Are new participants being accepted for this trial at present?

"Affirmative. The details found on clinicaltrials.gov demonstrate that this medical trial is currently enlisting patients, with the initial posting date being November 26th 2018 and an update made as recently as April 7th 2022. A total of 200 participants are needed from a single site for the study's completion."

Answered by AI
~25 spots leftby Apr 2025